321 related articles for article (PubMed ID: 18420392)
1. Identification of gene transcript signatures predictive for estrogen receptor and lymph node status using a stepwise forward selection artificial neural network modelling approach.
Lancashire LJ; Rees RC; Ball GR
Artif Intell Med; 2008 Jun; 43(2):99-111. PubMed ID: 18420392
[TBL] [Abstract][Full Text] [Related]
2. Gene-expression profile changes correlated with tumor progression and lymph node metastasis in esophageal cancer.
Tamoto E; Tada M; Murakawa K; Takada M; Shindo G; Teramoto K; Matsunaga A; Komuro K; Kanai M; Kawakami A; Fujiwara Y; Kobayashi N; Shirata K; Nishimura N; Okushiba S; Kondo S; Hamada J; Yoshiki T; Moriuchi T; Katoh H
Clin Cancer Res; 2004 Jun; 10(11):3629-38. PubMed ID: 15173069
[TBL] [Abstract][Full Text] [Related]
3. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients.
Györffy B; Lanczky A; Eklund AC; Denkert C; Budczies J; Li Q; Szallasi Z
Breast Cancer Res Treat; 2010 Oct; 123(3):725-31. PubMed ID: 20020197
[TBL] [Abstract][Full Text] [Related]
4. Challenges in projecting clustering results across gene expression-profiling datasets.
Lusa L; McShane LM; Reid JF; De Cecco L; Ambrogi F; Biganzoli E; Gariboldi M; Pierotti MA
J Natl Cancer Inst; 2007 Nov; 99(22):1715-23. PubMed ID: 18000217
[TBL] [Abstract][Full Text] [Related]
5. Predicting features of breast cancer with gene expression patterns.
Lu X; Lu X; Wang ZC; Iglehart JD; Zhang X; Richardson AL
Breast Cancer Res Treat; 2008 Mar; 108(2):191-201. PubMed ID: 18297396
[TBL] [Abstract][Full Text] [Related]
6. Prediction of lymph node metastasis with use of artificial neural networks based on gene expression profiles in esophageal squamous cell carcinoma.
Kan T; Shimada Y; Sato F; Ito T; Kondo K; Watanabe G; Maeda M; Yamasaki S; Meltzer SJ; Imamura M
Ann Surg Oncol; 2004 Dec; 11(12):1070-8. PubMed ID: 15545505
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns.
Gruvberger S; Ringnér M; Chen Y; Panavally S; Saal LH; Borg A ; Fernö M; Peterson C; Meltzer PS
Cancer Res; 2001 Aug; 61(16):5979-84. PubMed ID: 11507038
[TBL] [Abstract][Full Text] [Related]
8. Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer.
Yu JX; Sieuwerts AM; Zhang Y; Martens JW; Smid M; Klijn JG; Wang Y; Foekens JA
BMC Cancer; 2007 Sep; 7():182. PubMed ID: 17894856
[TBL] [Abstract][Full Text] [Related]
9. Gene expression signature and the prediction of lymph node metastasis in colorectal cancer by DNA microarray.
Watanabe T; Kobunai T; Tanaka T; Ishihara S; Matsuda K; Nagawa H
Dis Colon Rectum; 2009 Dec; 52(12):1941-8. PubMed ID: 19934913
[TBL] [Abstract][Full Text] [Related]
10. Limits of predictive models using microarray data for breast cancer clinical treatment outcome.
Reid JF; Lusa L; De Cecco L; Coradini D; Veneroni S; Daidone MG; Gariboldi M; Pierotti MA
J Natl Cancer Inst; 2005 Jun; 97(12):927-30. PubMed ID: 15956654
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy.
Hartmann O; Spyratos F; Harbeck N; Dietrich D; Fassbender A; Schmitt M; Eppenberger-Castori S; Vuaroqueaux V; Lerebours F; Welzel K; Maier S; Plum A; Niemann S; Foekens JA; Lesche R; Martens JW
Clin Cancer Res; 2009 Jan; 15(1):315-23. PubMed ID: 19118060
[TBL] [Abstract][Full Text] [Related]
12. Transcriptomic signatures in breast cancer.
Fu J; Jeffrey SS
Mol Biosyst; 2007 Jul; 3(7):466-72. PubMed ID: 17579771
[TBL] [Abstract][Full Text] [Related]
13. Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?
Correa Geyer F; Reis-Filho JS
Int J Surg Pathol; 2009 Aug; 17(4):285-302. PubMed ID: 19103611
[TBL] [Abstract][Full Text] [Related]
14. A six-gene signature predicting breast cancer lung metastasis.
Landemaine T; Jackson A; Bellahcène A; Rucci N; Sin S; Abad BM; Sierra A; Boudinet A; Guinebretière JM; Ricevuto E; Noguès C; Briffod M; Bièche I; Cherel P; Garcia T; Castronovo V; Teti A; Lidereau R; Driouch K
Cancer Res; 2008 Aug; 68(15):6092-9. PubMed ID: 18676831
[TBL] [Abstract][Full Text] [Related]
15. Gene expression signatures in breast cancer distinguish phenotype characteristics, histologic subtypes, and tumor invasiveness.
Pedraza V; Gomez-Capilla JA; Escaramis G; Gomez C; Torné P; Rivera JM; Gil A; Araque P; Olea N; Estivill X; Fárez-Vidal ME
Cancer; 2010 Jan; 116(2):486-96. PubMed ID: 20029976
[TBL] [Abstract][Full Text] [Related]
16. Using support vector regression to model the correlation between the clinical metastases time and gene expression profile for breast cancer.
Chiu SH; Chen CC; Lin TH
Artif Intell Med; 2008 Nov; 44(3):221-31. PubMed ID: 18678474
[TBL] [Abstract][Full Text] [Related]
17. Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.
Ross JS
Adv Anat Pathol; 2009 Jul; 16(4):204-15. PubMed ID: 19546609
[TBL] [Abstract][Full Text] [Related]
18. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
19. Prognostic applications of gene expression signatures in breast cancer.
Normanno N; De Luca A; Carotenuto P; Lamura L; Oliva I; D'Alessio A
Oncology; 2009; 77 Suppl 1():2-8. PubMed ID: 20130425
[TBL] [Abstract][Full Text] [Related]
20. Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer.
Calabrò A; Beissbarth T; Kuner R; Stojanov M; Benner A; Asslaber M; Ploner F; Zatloukal K; Samonigg H; Poustka A; Sültmann H
Breast Cancer Res Treat; 2009 Jul; 116(1):69-77. PubMed ID: 18592372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
